Ranking Vaccines A Prioritization Framework: Phase I: Demonstration of Concept and a Software Blueprint |
|
| Author:
| Institute of Medicine,
Board on Global Health,
Board on Population Health and Public Health Practice,
Committee on Identifying and Prioritizing New Preventive Vaccines for Development, |
| Editor:
| King, Lonnie
Martinez, Rose-Marie
Lieu, Tracy
Fryback, Dennis
Phelps, Charles
Sangha, Kinpritma
Madharan, Guruprasad |
| ISBN: | 978-0-309-25528-8 |
| Publication Date: | Sep 2012 |
| Publisher: | National Academies Press
|
| Book Format: | Ebook |
| List Price: | USD $48.99 |
Book Description:
|
As a number of diseases emerge or reemerge thus stimulating new vaccine development opportunities to help prevent those diseases, it can be especially difficult for decision makers to know where to invest their limited resources. Therefore, it is increasingly important for decision makers to have the tools that can assist and inform their vaccine prioritization efforts.
In this first phase report, the IOM offers a framework and proof of concept to account for various factors...
More Description
As a number of diseases emerge or reemerge thus stimulating new vaccine development opportunities to help prevent those diseases, it can be especially difficult for decision makers to know where to invest their limited resources. Therefore, it is increasingly important for decision makers to have the tools that can assist and inform their vaccine prioritization efforts.
In this first phase report, the IOM offers a framework and proof of concept to account for various factors influencing vaccine prioritization-demographic, economic, health, scientific, business, programmatic, social, policy factors and public concerns. Ranking Vaccines: A Prioritization Framework describes a decision-support model and the blueprint of a software-called Strategic Multi-Attribute Ranking Tool for Vaccines or SMART Vaccines. SMART Vaccines should be of help to decision makers. SMART Vaccines Beta is not available for public use, but SMART Vaccines 1.0 is expected to be released at the end of the second phase of this study, when it will be fully operational and capable of guiding discussions about prioritizing the development and introduction of new vaccines.